Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies.
Alternative perfusion technique without axillary artery cannulation during combined aortic root and total arch replacement.
Retrospective Assessment of Occupational Exposures for the GENEVA Study of ALS among Military Veterans.
Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential.
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
See All 29 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
Usami Y, Wu Y, G?ttlinger HG. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature. 2015 Oct 08; 526(7572):218-23.
View in:
PubMed
subject areas
CD4-Positive T-Lymphocytes
Cell Line
Down-Regulation
Gene Deletion
Gene Products, gag
HIV Infections
HIV-1
Host-Pathogen Interactions
Humans
Leukemia Virus, Murine
Membrane Glycoproteins
Membrane Proteins
nef Gene Products, Human Immunodeficiency Virus
Neoplasm Proteins
Protein Transport
Receptors, Cell Surface
Virion
Virus Replication
authors with profiles
Yoshiko Usami PhD
Yuanfei Wu MD, PhD